These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15340230)

  • 1. Intestinal absorption and hepatic extraction of propranolol and metoprolol in rats with bilateral ureteral ligation.
    Okabe H; Higashi T; Ohta T; Hashimoto Y
    Biol Pharm Bull; 2004 Sep; 27(9):1422-7. PubMed ID: 15340230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous uremic substances are not involved in the reduced hepatic extraction of metoprolol in bilateral ureter-ligated rats.
    Taguchi M; Urai M; Taira S; Tanabe H; Hashimoto Y
    Drug Metab Pharmacokinet; 2006 Apr; 21(2):156-64. PubMed ID: 16702736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism responsible for the decreased hepatic NADPH generation rate in rats with bilateral ureter ligation-induced renal failure.
    Higashi T; Urai M; Taguchi M; Hashimoto Y
    Biol Pharm Bull; 2005 Sep; 28(9):1809-12. PubMed ID: 16141568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and hepatic extraction of metoprolol in rats with glycerol-induced acute renal failure.
    Tanabe H; Taira S; Taguchi M; Hashimoto Y
    Biol Pharm Bull; 2007 Mar; 30(3):552-5. PubMed ID: 17329855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The increased intestinal absorption rate is responsible for the reduced hepatic first-pass extraction of propranolol in rats with cisplatin-induced renal dysfunction.
    Okabe H; Mizukami A; Taguchi M; Aiba T; Yasuhara M; Hashimoto Y
    J Pharm Pharmacol; 2003 Apr; 55(4):479-86. PubMed ID: 12803769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered S(--)-propranolol disposition in bilateral ureter-ligated rats.
    Laganière S; Shen DD
    Nephron; 1987; 46(3):305-11. PubMed ID: 3627324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of bisoprolol in rats with bilateral ureter ligation-induced renal failure.
    Tahara K; Saigusa K; Kagawa Y; Taguchi M; Hashimoto Y
    Drug Metab Pharmacokinet; 2006 Oct; 21(5):389-94. PubMed ID: 17072092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat.
    Belpaire FM; de Smet F; Chindavijak B; Fraeyman N; Bogaert MG
    Fundam Clin Pharmacol; 1989; 3(2):79-88. PubMed ID: 2722116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of substrate depletion assay for early prediction of nonlinear pharmacokinetics in drug discovery: assessment of nonlinearity of metoprolol, timolol, and propranolol.
    Komura H; Kawase A; Iwaki M
    J Pharm Sci; 2005 Dec; 94(12):2656-66. PubMed ID: 16258981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hepatic and intestinal metabolic activities of P450 in rats with surgery- and drug-induced renal dysfunction.
    Okabe H; Hasunuma M; Hashimoto Y
    Pharm Res; 2003 Oct; 20(10):1591-4. PubMed ID: 14620512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aging on the pharmcokinetics of atenolol, metoprolol and propranolol in the rat.
    Belpaire FM; de Smet F; Vynckier LJ; Vermeulen AM; Rosseel MT; Bogaert MG; Chauvelot-Moachon L
    J Pharmacol Exp Ther; 1990 Jul; 254(1):116-22. PubMed ID: 2366179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species differences in the disposition of propranolol prodrugs derived from hydrolase activity in intestinal mucosa.
    Yoshigae Y; Imai T; Aso T; Otagiri M
    Life Sci; 1998; 62(14):1231-41. PubMed ID: 9570338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of hepatic metabolism affecting pharmacokinetics of propranolol in humans.
    Kiriyama A; Honbo A; Iga K
    Int J Pharm; 2008 Feb; 349(1-2):53-60. PubMed ID: 17765415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol.
    Yoon IS; Choi MK; Kim JS; Shim CK; Chung SJ; Kim DD
    Xenobiotica; 2011 Mar; 41(3):243-51. PubMed ID: 21128757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and metabolism of metoprolol and propranolol in the female DA and female Wistar rat: the female DA rat is not always an animal model for poor metabolizers of CYP2D6.
    Komura H; Iwaki M
    J Pharm Sci; 2005 Feb; 94(2):397-408. PubMed ID: 15614816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic pharmacokinetics of propranolol in rats with adjuvant-induced systemic inflammation.
    Hung DY; Siebert GA; Chang P; Whitehouse MW; Fletcher L; Crawford DH; Roberts MS
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G343-51. PubMed ID: 16166348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating barriers to bioavailability in vivo: validation of a technique for separately assessing gastrointestinal absorption and hepatic extraction.
    Letendre L; Scott M; Dobson G; Hidalgo I; Aungst B
    Pharm Res; 2004 Aug; 21(8):1457-62. PubMed ID: 15359582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.
    Li P; Robertson TA; Zhang Q; Fletcher LM; Crawford DH; Weiss M; Roberts MS
    Pharm Res; 2012 Jun; 29(6):1658-69. PubMed ID: 22302523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucosamine modulates propranolol pharmacokinetics via intestinal permeability in rats.
    Al Shaker HA; Qinna NA; Badr M; Al Omari MMH; Idkaidek N; Matalka KZ; Badwan AA
    Eur J Pharm Sci; 2017 Jul; 105():137-143. PubMed ID: 28502673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of an ex vivo method for determination of intestinal permeability of drugs using everted rat intestine apparatus.
    Dixit P; Jain DK; Dumbwani J
    J Pharmacol Toxicol Methods; 2012 Jan; 65(1):13-7. PubMed ID: 22107724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.